retatrutide latest clinical trial results trials phase approval: FDA status, results, and when it could be available Do not obsess over Retatrutide. – Phase III retatrutide study demonstrates – retatrutide clinical results New Phase

Image credit: Pixel-Shot/Shutterstock.com After analyzing evidence from trials involving more than 8,000 people, researchers found that GLP-1 weight-loss drugs were linked to lower binge-eating severity, reduced loss of control around food, and less disinhibited eating in adults with overweight or obesity

Morgue case updates: Ex-Harvard morgue manager Cedric Lodge has agreed to plead guilty to stealing body parts from cadavers and selling them over state lines

In the GLP-1 space, there are specific products FDA-approved for diabetes and specific products approved for weight loss

After 24 weeks of treatment, significant reductions in neuropathy symptom and disability scores and in neurophysiological parameters were seen in both groups, with no difference between the two drugs safety-wise

doi: 10.1001/jamanetworkopen.2023.14493 142 WhartonSBlevinsTConneryLRosenstockJRahaSLiuRet al